Denmark - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Denmark Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry increased 5.4% year on year. In 2019, the country was number 8 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry with $1,510,421,981.56 Million PPP. Denmark is overtaken by South Korea, which was number 7 with $1,800,532,171.69 Million PPP and is followed by Spain at $1,127,374,718.22 Million PPP. United States ranked the highest with $70,565,318,932.39 Million PPP in 2019, +3.3% compared to 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 1,510,421,981.56 |
| 2018 | 1,469,658,410.46 |
| 2017 | 1,414,436,140.01 |
| 2016 | 1,484,668,253.45 |
| 2015 | 1,239,012,460.54 |
How does Denmark rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 7 |
#7
South Korea
|
1,800,532,171.69 | 2019 | +4.1 % | +6.9 % | View data | |
| 8 |
#8
Denmark
|
1,510,421,981.56 | 2019 | +2.8 % | +5.4 % | View data | |
| 9 |
#9
Spain
|
1,127,374,718.22 | 2019 | +2.6 % | +5.3 % | View data | |